Rapid Dose Therapeutics Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DOSE.CN research report →
Companywww.rapid-dose.com
Rapid Dose Therapeutics Corp. , a life sciences company, provides drug delivery technologies designed to enhance outcomes and quality of lives in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active ingredients into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system.
- CEO
- Mark Andrew Upsdell
- IPO
- 2010
- Employees
- 12
- HQ
- Burlington, ON, CA
Price Chart
Valuation
- Market Cap
- $12.53M
- P/E
- -2.86
- P/S
- 4.50
- P/B
- -1.88
- EV/EBITDA
- -7.89
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 29.82%
- Op Margin
- -110.68%
- Net Margin
- -157.17%
- ROE
- 75.85%
- ROIC
- 543.76%
Growth & Income
- Revenue
- $2.09M · 104.43%
- Net Income
- $-5,404,265 · -25.51%
- EPS
- $-0.04 · -5.85%
- Op Income
- $5.40M
- FCF YoY
- 49.78%
Performance & Tape
- 52W High
- $0.24
- 52W Low
- $0.09
- 50D MA
- $0.11
- 200D MA
- $0.14
- Beta
- -0.69
- Avg Volume
- 109.51K
Get TickerSpark's AI analysis on DOSE.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our DOSE.CN Coverage
We haven't published any research on DOSE.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DOSE.CN Report →